$CYDY
CytoDyn Inc.

2019 Q2 Form 10-K Financial Statement

#000119312519221300 Filed on August 14, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2 2018
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.111M $2.190M $7.341M
YoY Change 87.74% 3.79% 8.61%
% of Gross Profit
Research & Development $9.195M $8.920M $38.22M
YoY Change 3.09% 59.29% 89.17%
% of Gross Profit
Depreciation & Amortization $497.5K $90.00K $356.1K
YoY Change 452.76% 0.0% -2.8%
% of Gross Profit
Operating Expenses $13.80M $11.20M $45.92M
YoY Change 23.29% 43.56% 68.01%
Operating Profit -$45.92M
YoY Change 68.01%
Interest Expense -$1.090M $393.7K $5.925M
YoY Change -376.78% -59.41% 866.91%
% of Operating Profit
Other Income/Expense, Net $0.00 $1.967M -$826.3K
YoY Change -100.0% 102.78% 34.84%
Pretax Income -$14.89M -$9.620M -$50.15M
YoY Change 54.82% 40.85% 94.65%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$14.89M -$9.624M -$50.15M
YoY Change 54.76% 40.91% 94.65%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$47.18K -$45.34K -$286.8K
COMMON SHARES
Basic Shares Outstanding 364.7M 218.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2018 Q2 2018
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.613M $1.230M $1.231M
YoY Change 112.43% -30.9% -30.65%
Cash & Equivalents $2.613M $1.231M
Short-Term Investments
Other Short-Term Assets $2.666M $2.090M $2.089M
YoY Change 27.54% -51.95% -51.92%
Inventory
Prepaid Expenses $107.2K $227.2K
Receivables
Other Receivables
Total Short-Term Assets $5.369M $3.321M $3.321M
YoY Change 61.7% -45.75% -45.75%
LONG-TERM ASSETS
Property, Plant & Equipment $29.25K $11.23K $11.23K
YoY Change 160.52% -35.03% -35.01%
Goodwill
YoY Change
Intangibles $15.48M $1.567M
YoY Change 887.49% -18.26%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $15.50M $1.578M $1.578M
YoY Change 882.32% -18.41% -18.41%
TOTAL ASSETS
Total Short-Term Assets $5.369M $3.321M $3.321M
Total Long-Term Assets $15.50M $1.578M $1.578M
Total Assets $20.87M $4.899M $4.899M
YoY Change 326.09% -39.18% -39.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.24M $15.84M $15.84M
YoY Change 2.51% 270.03% 270.03%
Accrued Expenses $160.0K $57.98K $891.4K
YoY Change 175.94% -92.75% 10.84%
Deferred Revenue
YoY Change
Short-Term Debt $3.586M $0.00 $0.00
YoY Change
Long-Term Debt Due $4.200M $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $26.93M $16.73M $16.73M
YoY Change 60.92% 172.35% 172.35%
LONG-TERM LIABILITIES
Long-Term Debt $454.6K $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.407M $1.320M $1.324M
YoY Change 82.37% -56.15% -56.09%
Total Long-Term Liabilities $2.862M $1.324M $1.324M
YoY Change 116.19% -56.09% -56.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.93M $16.73M $16.73M
Total Long-Term Liabilities $2.862M $1.324M $1.324M
Total Liabilities $29.79M $18.06M $18.06M
YoY Change 64.97% 97.16% 97.16%
SHAREHOLDERS EQUITY
Retained Earnings -$234.4M -$173.1M
YoY Change 35.39% 40.78%
Common Stock $329.6K $216.9K
YoY Change 51.95% 45.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$8.913M -$13.16M -$13.16M
YoY Change
Total Liabilities & Shareholders Equity $20.87M $4.899M $4.899M
YoY Change 326.09% -39.18% -39.18%

Cashflow Statement

Concept 2019 Q2 2018 Q2 2018
OPERATING ACTIVITIES
Net Income -$14.89M -$9.624M -$50.15M
YoY Change 54.76% 40.91% 94.65%
Depreciation, Depletion And Amortization $497.5K $90.00K $356.1K
YoY Change 452.76% 0.0% -2.8%
Cash From Operating Activities -$9.512M -$6.980M -$29.90M
YoY Change 36.28% -2.51% 11.84%
INVESTING ACTIVITIES
Capital Expenditures -$42.10K $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$42.10K $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $8.990M
YoY Change 0.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.43M 3.260M 29.35M
YoY Change 250.53% 183.48% 55.5%
NET CHANGE
Cash From Operating Activities -9.512M -6.980M -29.90M
Cash From Investing Activities -42.10K 0.000 0.000
Cash From Financing Activities 11.43M 3.260M 29.35M
Net Change In Cash 1.873M -3.720M -544.1K
YoY Change -150.35% -38.1% -93.08%
FREE CASH FLOW
Cash From Operating Activities -$9.512M -$6.980M -$29.90M
Capital Expenditures -$42.10K $0.00 $0.00
Free Cash Flow -$9.470M -$6.980M -$29.90M
YoY Change 35.68% -2.51% 11.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29251
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11228
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15475454
CY2018Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1567143
CY2019Q2 us-gaap Assets
Assets
20874125
CY2018Q2 us-gaap Assets
Assets
4898998
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2612910
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1231445
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
107211
CY2018Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
227173
CY2019Q2 cydy Prepaid Service Fees Current
PrepaidServiceFeesCurrent
1704876
CY2018Q2 cydy Prepaid Service Fees Current
PrepaidServiceFeesCurrent
1862009
CY2019Q2 us-gaap Assets Current
AssetsCurrent
5369420
CY2018Q2 us-gaap Assets Current
AssetsCurrent
3320627
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
16239434
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
15841859
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1588552
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
757778
CY2019Q2 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
208600
CY2018Q2 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
133600
CY2019Q2 us-gaap Interest Payable Current
InterestPayableCurrent
212777
CY2019Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3586035
CY2019Q2 us-gaap Liabilities
Liabilities
29788185
CY2018Q2 us-gaap Liabilities
Liabilities
18056969
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20874125
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4898998
CY2018Q2 us-gaap Interest Payable Current
InterestPayableCurrent
0
CY2018Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
26926348
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
16733237
CY2019Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
454568
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-173139396
CY2019Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
159
CY2019 us-gaap Interest Expense Debt
InterestExpenseDebt
950617
CY2019Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2861837
CY2018 us-gaap Interest Expense Debt
InterestExpenseDebt
251315
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50466164
CY2018Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1323732
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-13157971
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
329555
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
216881
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1741370
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-8914060
CY2018Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
159
CY2018Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0
CY2019 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
459085
CY2018 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
435609
CY2019 us-gaap Interest Expense
InterestExpense
3312697
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
CY2017 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
0
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12116743
CY2018 us-gaap Interest Expense
InterestExpense
5924923
CY2017 us-gaap Interest Expense
InterestExpense
612767
CY2017 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7340605
CY2019 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1666469
CY2018 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1690935
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59013579
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-50149681
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6758606
CY2017 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2164533
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25763801
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2826919
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.21
CY2018 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.29
CY2017 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.19
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42490144
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38222580
CY2019 us-gaap Operating Expenses
OperatingExpenses
55852054
CY2018 us-gaap Operating Expenses
OperatingExpenses
45919313
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-55852054
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-45919313
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
4306
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
3620
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20205743
CY2017 us-gaap Operating Expenses
OperatingExpenses
27330734
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-27330734
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
15167
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
272040933
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
174885422
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
138004461
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1245167
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
356128
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
459085
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
435609
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1707068
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1666017
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
3388095
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
1290777
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
464201
CY2018 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2256173
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12365959
CY2019 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
38268839
CY2018 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3161131
CY2018 cydy Interest Related To Warrant Extensions
InterestRelatedToWarrantExtensions
826252
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25731
CY2018 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
25224212
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
366385
CY2017 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3466509
CY2017 cydy Issuance Of Common Stock In Private Stock Offering Value
IssuanceOfCommonStockInPrivateStockOfferingValue
729500
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1204791
CY2017 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
397883
CY2017 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
19133755
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29897971
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45284
CY2019 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
4336426
CY2018 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
3558789
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52746512
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29353833
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2235064
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-544138
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1231445
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1775583
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2019 cydy Non Cash Finance Cost Associated With Placement Agents Warrants
NonCashFinanceCostAssociatedWithPlacementAgentsWarrants
260636
CY2018 cydy Non Cash Finance Cost Associated With Placement Agents Warrants
NonCashFinanceCostAssociatedWithPlacementAgentsWarrants
70383
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26732468
CY2017 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1804249
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18877389
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7866193
CY2016Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9641776
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11114
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11114
CY2017 cydy Non Cash Finance Cost Associated With Placement Agents Warrants
NonCashFinanceCostAssociatedWithPlacementAgentsWarrants
0
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-229363407
CY2019Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
3300000
CY2018Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1100000
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3855468
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1323732
CY2019Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2407269
CY2019Q2 cydy Treasury Stock Par Value
TreasuryStockParValue
0.001
CY2019 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
159011
CY2010Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1519603
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2826919
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2019 us-gaap Interest Paid Net
InterestPaidNet
0
CY2018 us-gaap Interest Paid Net
InterestPaidNet
9157
CY2019 cydy Accrued Interest To Convertible Note Payable
AccruedInterestToConvertibleNotePayable
225245
CY2018 cydy Accrued Interest To Convertible Note Payable
AccruedInterestToConvertibleNotePayable
0
CY2019 cydy Non Cash Derivative Liability Associated With Convertible Note Payable
NonCashDerivativeLiabilityAssociatedWithConvertibleNotePayable
2750006
CY2018 cydy Non Cash Derivative Liability Associated With Convertible Note Payable
NonCashDerivativeLiabilityAssociatedWithConvertibleNotePayable
0
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0
CY2018 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
5788500
CY2019 us-gaap Stock Issued1
StockIssued1
0
CY2018 us-gaap Stock Issued1
StockIssued1
242158
CY2019 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
260190
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2017 us-gaap Interest Paid Net
InterestPaidNet
0
CY2017 cydy Accrued Interest To Convertible Note Payable
AccruedInterestToConvertibleNotePayable
0
CY2017 cydy Non Cash Derivative Liability Associated With Convertible Note Payable
NonCashDerivativeLiabilityAssociatedWithConvertibleNotePayable
0
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0
CY2017 us-gaap Stock Issued1
StockIssued1
0
CY2017 cydy Issuance Of Common Stock In Registered Direct Offering Value
IssuanceOfCommonStockInRegisteredDirectOfferingValue
14044252
CY2019 cydy Debt Instrument Amendments
DebtInstrumentAmendments
111410
CY2019Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4654568
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1204791
CY2019 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0
CY2019 cydy Issuance Of Common Stock In Private Stock Offering Value
IssuanceOfCommonStockInPrivateStockOfferingValue
23487584
CY2019 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Private Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToPrivateOffering
-2697149
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3388095
CY2019 cydy Issuance Of Common Stock In Registered Direct Offering Value
IssuanceOfCommonStockInRegisteredDirectOfferingValue
11814739
CY2019 cydy Stock Issue During Period Value Offering Costs Related To Registered Direct Offering
StockIssueDuringPeriodValueOfferingCostsRelatedToRegisteredDirectOffering
-1129516
CY2019Q1 cydy Relative Fair Value Of Equity Classified Warrants
RelativeFairValueOfEquityClassifiedWarrants
858353
CY2019Q1 cydy Warrants At Beneficial Conversion Feature
WarrantsAtBeneficialConversionFeature
2676639
CY2019Q1 cydy Proceeds From Issuance Of Convertible Promissory Notes
ProceedsFromIssuanceOfConvertiblePromissoryNotes
5000000
CY2019 cydy Stock Options And Warrants Grants In Period
StockOptionsAndWarrantsGrantsInPeriod
64834121
CY2019 cydy Stock Options And Warrants Grants In Period Weighted Average Exercise Price
StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
0.57
CY2019 cydy Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.81
CY2019Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.71
CY2019 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P3Y9M
CY2019Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
896400
CY2019Q2 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageExercisePrice
0.71
CY2019 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Remaining Contractual Term
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageRemainingContractualTerm
P3Y7M27D
CY2019Q2 cydy Stock Options And Warrants Outstanding Exercisable Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingExercisableAggregateIntrinsicValue
896400
CY2019 cydy Stock Options And Warrants Exercised In Period
StockOptionsAndWarrantsExercisedInPeriod
7541279
CY2019 cydy Stock Options And Warrants Exercised In Period Weighted Average Exercise Price
StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice
0.40
CY2019 cydy Stock Options And Warrants Forfeitures And Expirations In Period
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod
11086262
CY2019Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
178591849
CY2019Q2 cydy Stock Options And Warrants Outstanding Exercisable Number
StockOptionsAndWarrantsOutstandingExercisableNumber
175116515
CY2019Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3500000
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3170315
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1968846
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15475454
CY2018Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1531154
CY2019Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0
CY2018Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
35989
CY2019Q2 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
300000
CY2019Q2 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
365000
CY2019 cydy Asset Purchase Agreement Aggregate Consideration Paying Period
AssetPurchaseAgreementAggregateConsiderationPayingPeriod
P10Y
CY2016 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
1500000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
150000
CY2019Q2 cydy Long Term Convertible Notes Payable Current
LongTermConvertibleNotesPayableCurrent
4200000
CY2018Q2 cydy Long Term Convertible Notes Payable Current
LongTermConvertibleNotesPayableCurrent
0
CY2019 cydy Interest Expense Related To Accretion Of Convertible Notes Payable
InterestExpenseRelatedToAccretionOfConvertibleNotesPayable
512594
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
583200
CY2019 us-gaap Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset
ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset
3534992
CY2019 cydy Non Cash Consideratiuon For Issue Of Common Stock In Connection With An Employment Agreeement
NonCashConsideratiuonForIssueOfCommonStockInConnectionWithAnEmploymentAgreeement
8342
CY2019 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
1455000
CY2018 us-gaap Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset
ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset
0
CY2018 cydy Non Cash Consideratiuon For Issue Of Common Stock In Connection With An Employment Agreeement
NonCashConsideratiuonForIssueOfCommonStockInConnectionWithAnEmploymentAgreeement
0
CY2018 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0
CY2017 us-gaap Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset
ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset
0
CY2017 cydy Non Cash Consideratiuon For Issue Of Common Stock In Connection With An Employment Agreeement
NonCashConsideratiuonForIssueOfCommonStockInConnectionWithAnEmploymentAgreeement
0
CY2017 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0
CY2019 cydy Adjustments To Additional Paid In Capital Offering Costs Related To Debt Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostsRelatedToDebtOffering
260636
CY2019 cydy Adjustments To Additional Paid In Capital Debt Discount And Issuance Costs Related To Debt Offering
AdjustmentsToAdditionalPaidInCapitalDebtDiscountAndIssuanceCostsRelatedToDebtOffering
3059159
CY2019 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
3534992
CY2019 cydy Stock Issued During Period Value Redemption Of Note Payable
StockIssuedDuringPeriodValueRedemptionOfNotePayable
1455000
CY2019 cydy Debt Instrument Periodic Addition Payment
DebtInstrumentPeriodicAdditionPayment
0
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
150,000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1145834
CY2019Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
853599
CY2018Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2019Q2 cydy Miscellaneous Receivables Current
MiscellaneousReceivablesCurrent
90824
CY2018Q2 cydy Miscellaneous Receivables Current
MiscellaneousReceivablesCurrent
0
CY2019Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2407269
CY2018Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1323732
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
220119856
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
159764611
CY2017 cydy Interest Expense Related To Accretion Of Convertible Notes Payable
InterestExpenseRelatedToAccretionOfConvertibleNotesPayable
0
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-size:10pt; color:#000000; font-family:'times new roman'; font-style:normal; font-variant-ligatures:normal; font-variant-caps:normal; font-weight:400; letter-spacing:normal; orphans:2; text-align:start; text-indent:0px; text-transform:none; white-space:normal; widows:2; word-spacing:0px; -webkit-text-stroke-width:0px; text-decoration-style:initial; text-decoration-color:initial; margin-top:18pt; margin-bottom:0pt"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div><div style="font-size:10pt; color:#000000; font-family:'times new roman'; font-style:normal; font-variant-ligatures:normal; font-variant-caps:normal; font-weight:400; letter-spacing:normal; orphans:2; text-align:start; text-indent:0px; text-transform:none; white-space:normal; widows:2; word-spacing:0px; -webkit-text-stroke-width:0px; text-decoration-style:initial; text-decoration-color:initial; margin-top:6pt; margin-bottom:0pt"><div style="color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
375000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
329554763
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
216881790
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
329395752
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
216722779
CY2019 cydy Increase Decrease In Miscellaneous Receivables
IncreaseDecreaseInMiscellaneousReceivables
-90824
CY2019 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
15460000
CY2018 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4888500
CY2019 cydy Interest Expense Related To Derivative Liability
InterestExpenseRelatedToDerivativeLiability
0
CY2018 cydy Interest Expense Related To Derivative Liability
InterestExpenseRelatedToDerivativeLiability
0
CY2017 cydy Interest Expense Related To Derivative Liability
InterestExpenseRelatedToDerivativeLiability
540330
CY2019 cydy Interest Related To Warrant Tender Offer
InterestRelatedToWarrantTenderOffer
195927
CY2018 cydy Interest Related To Warrant Tender Offer
InterestRelatedToWarrantTenderOffer
393685
CY2017 cydy Interest Related To Warrant Tender Offer
InterestRelatedToWarrantTenderOffer
0
CY2019 cydy Interest Related To Warrant Extensions
InterestRelatedToWarrantExtensions
0
CY2017 cydy Interest Related To Warrant Extensions
InterestRelatedToWarrantExtensions
72437
CY2019 cydy Interest Related To Convertible Debt
InterestRelatedToConvertibleDebt
0
CY2018 cydy Interest Related To Convertible Debt
InterestRelatedToConvertibleDebt
2352045
CY2017 cydy Interest Related To Convertible Debt
InterestRelatedToConvertibleDebt
0
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2019 cydy Interest Expense On Conversion Inducement
InterestExpenseOnConversionInducement
195927
CY2018 cydy Interest Expense On Conversion Inducement
InterestExpenseOnConversionInducement
0
CY2017 cydy Interest Expense On Conversion Inducement
InterestExpenseOnConversionInducement
72437
CY2018 cydy Interest Expense Related To Accretion Of Convertible Notes Payable
InterestExpenseRelatedToAccretionOfConvertibleNotesPayable
0
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1504712
CY2018 cydy Increase Decrease In Miscellaneous Receivables
IncreaseDecreaseInMiscellaneousReceivables
0
CY2017 cydy Increase Decrease In Miscellaneous Receivables
IncreaseDecreaseInMiscellaneousReceivables
0
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2492789
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
19553
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2019 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
3083700
CY2018 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0
CY2017 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0
CY2017 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1150000
CY2018 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2017 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
102064
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
CY2018 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
259157
CY2017 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
CY2019 cydy Proceeds From Warrant Tender Offer Held In Trust
ProceedsFromWarrantTenderOfferHeldInTrust
853599
CY2018 cydy Proceeds From Warrant Tender Offer Held In Trust
ProceedsFromWarrantTenderOfferHeldInTrust
0
CY2017 cydy Proceeds From Warrant Tender Offer Held In Trust
ProceedsFromWarrantTenderOfferHeldInTrust
0
CY2019 cydy Accrued Dividends On Series C Convertible Preferred Stock
AccruedDividendsOnSeriesCConvertiblePreferredStock
37351
CY2018 cydy Accrued Dividends On Series C Convertible Preferred Stock
AccruedDividendsOnSeriesCConvertiblePreferredStock
0
CY2017 cydy Accrued Dividends On Series C Convertible Preferred Stock
AccruedDividendsOnSeriesCConvertiblePreferredStock
0
CY2019 cydy Non Cash Finance Cost Associated With Investors Warrants
NonCashFinanceCostAssociatedWithInvestorsWarrants
0
CY2018 cydy Non Cash Finance Cost Associated With Investors Warrants
NonCashFinanceCostAssociatedWithInvestorsWarrants
0
CY2017 cydy Non Cash Finance Cost Associated With Investors Warrants
NonCashFinanceCostAssociatedWithInvestorsWarrants
819200
CY2019 cydy Stock Issued During Period Value Issued For Accrued Bonus Compensation
StockIssuedDuringPeriodValueIssuedForAccruedBonusCompensation
0
CY2018 cydy Stock Issued During Period Value Issued For Accrued Bonus Compensation
StockIssuedDuringPeriodValueIssuedForAccruedBonusCompensation
214263
CY2017 cydy Stock Issued During Period Value Issued For Accrued Bonus Compensation
StockIssuedDuringPeriodValueIssuedForAccruedBonusCompensation
0
CY2019 cydy Non Cash Derivative Liability Associated With Warrants
NonCashDerivativeLiabilityAssociatedWithWarrants
0
CY2018 cydy Non Cash Derivative Liability Associated With Warrants
NonCashDerivativeLiabilityAssociatedWithWarrants
0
CY2017 cydy Non Cash Derivative Liability Associated With Warrants
NonCashDerivativeLiabilityAssociatedWithWarrants
5179200
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
178591849
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
132385269
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
77859626
CY2019 cydy Percentage Of Outstanding Common Stock To Be Acquired
PercentageOfOutstandingCommonStockToBeAcquired
0.50
CY2017 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
72434
CY2017 cydy Adjustments To Additional Paid In Capital Legal Fee With Registered Offerings
AdjustmentsToAdditionalPaidInCapitalLegalFeeWithRegisteredOfferings
-280883
CY2017 cydy Adjustments To Additional Paid In Capital Debt Discounts On Convertible Notes Payable
AdjustmentsToAdditionalPaidInCapitalDebtDiscountsOnConvertibleNotesPayable
91389
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1290777
CY2018 cydy Adjustment To Additional Paid In Capital Stock Issued For Board Compensation
AdjustmentToAdditionalPaidInCapitalStockIssuedForBoardCompensation
260190
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
104546
CY2019 cydy Tax Cuts And Jobs Act Of2017 Blended Tax Rate
TaxCutsAndJobsActOf2017BlendedTaxRate
0.21
CY2018 cydy Issuance Of Common Stock In Private Stock Offering Value
IssuanceOfCommonStockInPrivateStockOfferingValue
17643451
CY2018 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Private Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToPrivateOffering
-1717597
CY2018 cydy Issuance Of Common Stock In Registered Direct Offering Value
IssuanceOfCommonStockInRegisteredDirectOfferingValue
13611419
CY2018 cydy Adjustments To Additional Paid In Capital Legal Fees In Connection With Equity Offering
AdjustmentsToAdditionalPaidInCapitalLegalFeesInConnectionWithEquityOffering
-533436
CY2018 cydy Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
3161131
CY2018 cydy Adjustments To Additional Paid In Capital Debt Discounts On Convertible Notes Payable
AdjustmentsToAdditionalPaidInCapitalDebtDiscountsOnConvertibleNotesPayable
1645011
CY2018 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
826252
CY2018 cydy Adjustment To Additional Paid In Capital Interest Expense Related To Warrant Tender Offer
AdjustmentToAdditionalPaidInCapitalInterestExpenseRelatedToWarrantTenderOffer
393685
CY2018 cydy Adjustment To Additional Paid In Capital Interest Expense Related To Conversion Of Note Payable
AdjustmentToAdditionalPaidInCapitalInterestExpenseRelatedToConversionOfNotePayable
2352045
CY2019 cydy Stock Issued During Period Value Privatewarrant Exercised
StockIssuedDuringPeriodValuePrivatewarrantExercised
2966512
CY2019 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Exercise Of Warrants
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToExerciseOfWarrants
-266986
CY2019 cydy Adjustments To Additional Paid In Capital Inducement Of Interest Expense On Warrant Exchange
AdjustmentsToAdditionalPaidInCapitalInducementOfInterestExpenseOnWarrantExchange
195927
CY2019 cydy Stock Issued During Period Series C Convertible Stock Value
StockIssuedDuringPeriodSeriesCConvertibleStockValue
3083700
CY2019 cydy Dividends On Series C Preferred Stock
DividendsOnSeriesCPreferredStock
-37351
CY2019 cydy Adjustments To Additional Paid In Capital Legal Fees In Connection With Equity Offering
AdjustmentsToAdditionalPaidInCapitalLegalFeesInConnectionWithEquityOffering
-242771
CY2019 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
11558000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
10205450
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2000000
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700000
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1400000
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2000000
CY2019Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3500000
CY2018Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3500000
CY2019Q2 cydy Potential Royalty Payment As Percentage Of Net Sales
PotentialRoyaltyPaymentAsPercentageOfNetSales
0.02
CY2019Q2 cydy Percentage Of Shares Issuable Upon Exercise Of Original Warrants
PercentageOfSharesIssuableUponExerciseOfOriginalWarrants
0.50
CY2019Q2 us-gaap Share Price
SharePrice
0.40
CY2018Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
132385269
CY2018Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.80
CY2018Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
3673
CY2018 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P3Y9M10D
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.286
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.348
CY2019 cydy Effective Income Tax Rate Reconciliation Loss On Debt Conversion
EffectiveIncomeTaxRateReconciliationLossOnDebtConversion
-0.005
CY2019 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
0.006
CY2018 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
0.010
CY2017 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
0.028
CY2019 cydy Effective Income Tax Reconciliation Valuation Allowance From Asset Acquisition
EffectiveIncomeTaxReconciliationValuationAllowanceFromAssetAcquisition
0.048
CY2018 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Debt Issuance Costs Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtIssuanceCostsPercent
-0.002
CY2019 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Interest
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest
-0.003
CY2018 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Interest
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest
-0.001
CY2019 cydy Effective Income Tax Rate Reconciliation Inducement Charge
EffectiveIncomeTaxRateReconciliationInducementCharge
-0.001
CY2018 cydy Effective Income Tax Rate Reconciliation Inducement Charge
EffectiveIncomeTaxRateReconciliationInducementCharge
-0.020
CY2017 cydy Effective Income Tax Rate Reconciliation Inducement Charge
EffectiveIncomeTaxRateReconciliationInducementCharge
-0.010
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.011
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.044
CY2019 cydy Effective Income Tax Rate Reconciliation Tax Credit Carryforward
EffectiveIncomeTaxRateReconciliationTaxCreditCarryforward
-0.038
CY2018 cydy Effective Income Tax Rate Reconciliation Tax Credit Carryforward
EffectiveIncomeTaxRateReconciliationTaxCreditCarryforward
0.041
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.169
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.003
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.357
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.048
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
364748563
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-56186660
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-56186660
CY2018Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
139200000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-50149681
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0
CY2018Q2 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
CY2017Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
95600000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-25763801
CY2019 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
3059159
CY2018 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
1574628
CY2017 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
91389
CY2019Q1 cydy Warrants At Fair Value Of Redemption Provision
WarrantsAtFairValueOfRedemptionProvision
1465008
CY2019 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
3756406
CY2019Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
2407269
CY2018Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1323732
CY2019Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
190500000
CY2019Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
39996561
CY2018Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
29230279
CY2019Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2062692
CY2018Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
4260470
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
3628085
CY2018Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
2916585
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
251293
CY2018Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
117880
CY2019Q2 cydy Deferred Tax Assets Liabilities Net Property Plant And Equipment
DeferredTaxAssetsLiabilitiesNetPropertyPlantAndEquipment
-340
CY2018Q2 cydy Deferred Tax Assets Liabilities Net Property Plant And Equipment
DeferredTaxAssetsLiabilitiesNetPropertyPlantAndEquipment
174
CY2019Q2 cydy Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
329360
CY2018Q2 cydy Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
139875
CY2019Q2 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
308621
CY2019Q2 cydy Deferred Tax Assets Liability Difference In Acquired Assets
DeferredTaxAssetsLiabilityDifferenceInAcquiredAssets
2826919
CY2019Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
43132111
CY2018Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
36665263
CY2019Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0
CY2018Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0
CY2019Q2 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
43132111
CY2018Q2 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
36665263
CY2017 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Equity Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToEquityOffering
-1804249
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-1103234
CY2018 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Warrant Tender Offer
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToWarrantTenderOffer
-85381
CY2017Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.00
CY2017 cydy Issuance Of Common Stock In Registered Direct Offering Per Share
IssuanceOfCommonStockInRegisteredDirectOfferingPerShare
0.75
CY2018Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.50
CY2018 cydy Issuance Of Common Stock In Registered Direct Offering Per Share
IssuanceOfCommonStockInRegisteredDirectOfferingPerShare
0.50
CY2019Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.50
CY2019 cydy Issuance Of Common Stock In Registered Direct Offering Per Share
IssuanceOfCommonStockInRegisteredDirectOfferingPerShare
0.50
CY2019 cydy Estimated Future Unvested Option Forfeitures
EstimatedFutureUnvestedOptionForfeitures
0.0
CY2019 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2018 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2017 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2019Q2 cydy Pre Launch Inventory
PreLaunchInventory
0
CY2018Q2 cydy Pre Launch Inventory
PreLaunchInventory
0
CY2019Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
159011
CY2018Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
159011
CY2019 cydy Accretion Of Interest Expense On Debt
AccretionOfInterestExpenseOnDebt
298158
CY2019 dei Entity Registrant Name
EntityRegistrantName
CytoDyn Inc.
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001175680
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 cydy Convertible Promissory Note Maturity Period
ConvertiblePromissoryNoteMaturityPeriod
P2Y
CY2019Q2 cydy Tender Offer Proceeds Held In Trust
TenderOfferProceedsHeldInTrust
853599
CY2018Q2 cydy Tender Offer Proceeds Held In Trust
TenderOfferProceedsHeldInTrust
0
CY2019Q2 cydy Finitelived Intangible Assets Website Development Costs Incurred
FinitelivedIntangibleAssetsWebsiteDevelopmentCostsIncurred
19553
CY2019 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="color: rgb(0, 0, 0); font-family: 'times new roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt;"><div style="font-weight:bold;display:inline;">Reclassifications</div></div><div style="color: rgb(0, 0, 0); font-family: 'times new roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt;">Certain prior year amounts shown in the accompanying consolidated financial statements have been reclassified to conform to the 2019 presentation. These reclassifications did not have any effect on total current assets, total assets, total current liabilities, total liabilities, total stockholders&#8217; (deficit) equity, net loss or earnings per shares.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1984769
CY2018 cydy Stock Issue During Period Value Offering Costs Related To Registered Direct Offering
StockIssueDuringPeriodValueOfferingCostsRelatedToRegisteredDirectOffering
-85381
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-05-31
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018Q4 dei Entity Public Float
EntityPublicFloat
144497302
CY2019Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1200000
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer

Files In Submission

Name View Source Status
0001193125-19-221300-index-headers.html Edgar Link pending
0001193125-19-221300-index.html Edgar Link pending
0001193125-19-221300.txt Edgar Link pending
0001193125-19-221300-xbrl.zip Edgar Link pending
cydy-20190531.xml Edgar Link completed
cydy-20190531.xsd Edgar Link pending
cydy-20190531_cal.xml Edgar Link unprocessable
cydy-20190531_def.xml Edgar Link unprocessable
cydy-20190531_lab.xml Edgar Link unprocessable
cydy-20190531_pre.xml Edgar Link unprocessable
d40614d10k.htm Edgar Link pending
d40614dex1011.htm Edgar Link pending
d40614dex1012.htm Edgar Link pending
d40614dex21.htm Edgar Link pending
d40614dex23.htm Edgar Link pending
d40614dex24.htm Edgar Link pending
d40614dex311.htm Edgar Link pending
d40614dex312.htm Edgar Link pending
d40614dex32.htm Edgar Link pending
d40614dex418.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g40614614-1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending